After a literature review and comprehensive screening of the core targets, we identified six key targets (PIK3CA, IGF1R, RPS6KB1, INSR, PRKACA, and PPARG) that are significantly associated with THC’s effect in ameliorating NASH. This evidence concerns the gene IGF1R and metabolic dysfunction-associated steatohepatitis.